Are you Dr. Johnson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 626
Rochester, NY 14642Phone+1 585-276-3087Fax+1 585-273-1027
Summary
- Dr. Mahlon Johnson, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Tennessee. He is affiliated with Strong Memorial Hospital of the University of Rochester and is a Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
Vanderbilt University Medical CenterFellowship, Neuropathology, 1987 - 1989- Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1989
University of Tennessee Health Science Center College of MedicineClass of 1981
Certifications & Licensure
TN State Medical License 1981 - 2026
NY State Medical License 2006 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 12 citationsTransforming Growth Factor Beta Family in the Pathogenesis of Meningiomas.Mahlon D. Johnson
World Neurosurgery. 2017-08-01 - 377 citationsExpression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and OsteoarthritisRosa Serra, Mahlon D. Johnson, Ellen H. Filvaroff, James B. LaBorde, Daniel M. Sheehan
The Journal of Cell Biology. 1997-10-20 - 55 citationsLovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.Mahlon D. Johnson, Ann Woodard, Evelyn Okediji, Steven A. Toms, George S. Allen
Journal of Neuro-Oncology. 2002-01-01
Press Mentions
Low-Grade Fibromyxoid Tumor of the Dura: A New Entity?February 18th, 2024
